Sudarshan Pharma Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sudarshan Pharma Industries Ltd. on BSE

Search Inside the pdf :

Sudarshan Pharma Industries Ltd.

25 Jul 2025

26.75

3.92%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find attached the Scrutinizer''s Report on the business transacted at the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

25 Jul 2025

26.75

3.92%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find attached the voting results on the business transacted at the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 at 3.00 PM IST through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

25 Jul 2025

26.75

3.92%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Proceedings Of Annual General Meeting Held On 25Th July …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Proceedings of the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 at 3.00 p.m. IST through video conferencing / other audio visual means

pdf

Sudarshan Pharma Industries Ltd.

21 Jul 2025

26.75

3.92%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Please find enclosed the certificates received from the registrar and share transfer agent of the Company under Regulation 74(5) of SEBI (Depositories And Participants) Regulations, 2018 for the quarter ended 30/June/2025.

pdf

Sudarshan Pharma Industries Ltd.

17 Jul 2025

26.75

3.92%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Notice Of Extraordinary General Meeting Of The Company

BSE India

Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of Extraordinary General Meeting to be held on 11/August/2025 at 1.00 p.m. IST through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

02 Jul 2025

26.75

3.92%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed the newspaper advertisements for teh Notice of 17th Annual General Meeting of the Company published in (i) Mumbai Lakshdeep and (ii) Financial Express.

pdf

Sudarshan Pharma Industries Ltd.

01 Jul 2025

26.75

3.92%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Annual General Meeting On Friday, 25Th July 2025 At …

BSE India

The 17th Annual General Meeting of the members of the Company is scheduled to be held on Friday, 25th July 2025 at 3.00 p.m. IST through video conferencing / other audio-visual means.

pdf

Sudarshan Pharma Industries Ltd.

01 Jul 2025

26.75

3.92%

Corp. Note

Sudarshan Pharma Industries Ltd - 543828 - Reg. 34 (1) Annual Report.

BSE India

Annual Report of the Company for the financial year 2024-25 is attached herewith.

pdf

Sudarshan Pharma Industries Ltd.

30 Jun 2025, 11:16AM

26.75

3.92%

SAST

Sudarshan Pharma Industries Ltd - 543828 - Closure of Trading Window

BSE India

The Trading Window of the Company shall remain closed with effect from 1st July 2025 until the expiry of 48 hours after the declaration of financial results for the quarter ended 30th June 2025.

pdf

Sudarshan Pharma Industries Ltd.

19 Jun 2025

26.75

3.92%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

This is to inform you that the Board of Directors of the Company at their meeting held today i.e. 19/06/2025 have approved to incorporate a wholly-owned subsidiary Company in Canada.

pdf